The role of complement in experimental silicosis.

Area of Science:

• Immunology
• Pulmonary Medicine
• Toxicology

Background:

• Crystal-induced lung diseases, such as silicosis, involve complex inflammatory and fibrotic processes.
• The complement system is a critical component of innate immunity, implicated in various inflammatory conditions.

Purpose of the Study:

• To investigate the role of the complement system in the pathogenesis of crystal-induced pulmonary inflammation and fibrosis.
• To determine if complement deficiency impacts the development of silicosis in a mouse model.

Main Methods:

• Utilized a mouse model of silicosis with intratracheal instillation of silica crystals.
• Compared pulmonary changes in congenitally complement-deficient mice (lacking C5) with C5-sufficient mice.
• Assessed lung lavage fluid for cell number and protein content, and measured lung hydroxyproline for collagen deposition.

Main Results:

• Complement-deficient mice exhibited significantly reduced lung inflammation (lower cell and protein counts in lavage fluid) compared to sufficient mice post-silica exposure.
• Lung hydroxyproline content, a marker of fibrosis, was similar in both deficient and sufficient mice and increased significantly after silica exposure, indicating fibrosis occurred independently of complement.
• In vitro studies confirmed that silica crystals activate the complement system via the alternative pathway.

Conclusions:

• The complement system plays a significant role in mediating pulmonary inflammation following silica crystal exposure.
• Complement activation is not essential for the development of silica-induced pulmonary fibrosis.
• Targeting the complement system may be a potential therapeutic strategy for mitigating inflammation in silicosis.